Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
martes, octubre 13
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Alaunos Therapeutics Inc
TCRT
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$2.76
1.71
162.86%
Últ. Act.: Oct 13, 2:40 PM
$1.70
0.65
61.9%
Get Report
Panorámica general
Noticias
Previsión de beneficios
Finanzas
Sentimiento
Propiedad
Comparar
Informe de acciones
Privacy Manager
PRO
¿Por qué se mueve?:
Alaunos Therapeutics shares are trading higher after the company announced ...
Alaunos Therapeutics Financials
Alaunos Therapeutics (TCRT) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Alaunos Therapeutics Q2 EPS $(0.63) Up From $(0.71) YoY
Alaunos Therapeutics (NASDAQ:TCRT) reported quarterly losses of $(0.63) per share. This is a 11.27 percent increase over losses of $(0.71) per share from the same period last year.
Benzinga Newsdesk
Recap: Alaunos Therapeutics Q3 Earnings
Benzinga Insights
PRO
Alaunos Therapeutics Q3 EPS $(0.04), Same As Last Year
Alaunos Therapeutics (NASDAQ:TCRT) reported quarterly losses of $(0.04) per share. This is unchanged from the same period last year.
Benzinga Newsdesk
PRO
Alaunos Therapeutics Q2 EPS $(0.04), Inline
Alaunos Therapeutics (NASDAQ:TCRT) reported quarterly losses of $(0.04) per share which met the analyst consensus estimate. This is a 20 percent increase over losses of $(0.05) per share from the same period last year.
Benzinga Newsdesk
Earnings Scheduled For May 10, 2023
Companies Reporting Before The Bell • Nomad Foods (NYSE:NOMD) is projected to report quarterly earnings at $0.42 per share on revenue of $851.81 million.
Benzinga Insights
PRO
Alaunos Therapeutics Q1 EPS $(0.04), Inline
Alaunos Therapeutics (NASDAQ:TCRT) reported quarterly losses of $(0.04) per share which met the analyst consensus estimate. This is a 20 percent increase over losses of $(0.05) per share from the same period last year.
Benzinga Newsdesk
